Jinxin Fertility Group Limited (1951.HK)
1951.HK Stock Price Chart
Explore Jinxin Fertility Group Limited interactive price chart. Choose custom timeframes to analyze 1951.HK price movements and trends.
1951.HK Company Profile
Discover essential business fundamentals and corporate details for Jinxin Fertility Group Limited (1951.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
25 Jun 2019
Employees
3.20K
Website
https://www.jxr-fertility.comCEO
Yang Dong
Description
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.
1951.HK Financial Timeline
Browse a chronological timeline of Jinxin Fertility Group Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 25 Aug 2025
EPS came in at -$0.43 falling short of the estimated $0.05 by -880.00%, while revenue for the quarter reached $1.41B , missing expectations by -4.59%.
Earnings released on 28 Mar 2025
EPS came in at $0.04 falling short of the estimated $0.06 by -43.17%, while revenue for the quarter reached $1.46B , missing expectations by -11.22%.
Earnings released on 30 Aug 2024
EPS came in at $0.08 falling short of the estimated $0.09 by -12.22%, while revenue for the quarter reached $1.55B , missing expectations by -2.26%.
Dividend declared on 27 Jun 2024
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 25 Jul 2024.
Earnings released on 28 Mar 2024
EPS came in at $0.05 falling short of the estimated $0.07 by -25.80%, while revenue for the quarter reached $1.61B , missing expectations by -52.92%.
Earnings released on 30 Aug 2023
EPS came in at $0.09 surpassing the estimated $0.08 by +16.92%, while revenue for the quarter reached $1.44B , missing expectations by -2.24%.
Earnings released on 31 Mar 2023
EPS came in at -$0.03 , while revenue for the quarter reached $1.40B , missing expectations by -55.86%.
Earnings released on 1 Sept 2022
EPS came in at $0.09 , while revenue for the quarter reached $1.33B , missing expectations by -0.48%.
Dividend declared on 30 Jun 2022
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 22 Jul 2022.
Earnings released on 31 Mar 2022
EPS came in at $0.09 , while revenue for the quarter reached $1.20B .
Earnings released on 31 Aug 2021
EPS came in at $0.08 , while revenue for the quarter reached $1.03B .
Earnings released on 28 Mar 2021
EPS came in at $0.07 , while revenue for the quarter reached $967.02M .
Earnings released on 1 Sept 2020
EPS came in at $0.05 , while revenue for the quarter reached $671.61M .
1951.HK Stock Performance
Access detailed 1951.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.